TRCT
MSAC

Tower Research Capital (TRC)’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Tower Research Capital (TRC)’s Portfolio MSAC Stock Details MSAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,312
Closed -$13K – 6694
2022
Q4 		$13K Sell
1,312
-7
-0.5% -$70 ﹤0.01% 3662
2022
Q3 		$13K Sell
1,319
-400
-23% -$3.94K ﹤0.01% 4313
2022
Q2 		$17K Sell
1,719
-11
-0.6% -$108 ﹤0.01% 3990
2022
Q1 		$17K Buy
1,730
+613
+55% +$5.96K ﹤0.01% 3732
2021
Q4 		$11K Buy
+1,117
New +$10.9K ﹤0.01% 4506

Tower Research Capital (TRC)'s MSAC Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 1,312 shares — an estimated $13K sold.

Tower Research Capital (TRC) first reported a position in MSAC in Q4 2021 and held it in 5 quarters. The position peaked at $17K in Q2 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

  • Tower Research Capital (TRC) reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,312 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $13K.
  • Tower Research Capital (TRC) first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
  • Tower Research Capital (TRC)'s Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $17K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.